Danone Shares Dip at Close in a Lackluster Market
Danone closed the session on Monday, December 22, down 1% at 76.98 euros, losing 0.78 euros compared to the previous session's closing price of 77.76 euros. This decline marks a pause in the stock's upward trend, which still shows a gain of 1.16% for the week and 20.13% for the year. Trading volume was modest, with only 0.1% of the capital traded during the day, reflecting investor caution at year-end.
Despite Analyst Upgrades, Danone's Stock Retreats
Danone's decline occurred despite a recent target price upgrade from AlphaValue/Baader Europe, which raised its forecast from 79.70 to 80.10 euros while maintaining a 'reduce' recommendation. This new threshold, 4% above the current price, contrasts with the more neutral or conservative stances of other analysts: Bernstein keeps a target of 83 euros with a 'Neutral' rating, while HSBC targets 73 euros with a 'Hold' recommendation. This divergence reflects the market's ongoing caution about the stock's valuation, despite its strong annual performance.
Technical Uncertainties Surround Danone's Stock
Technically, Danone's stock is in a zone of uncertainty. It trades slightly below its 50-day moving average of 77.25 euros, yet remains above its 200-day moving average of 73.52 euros, confirming an underlying positive trend. The RSI stands at 53, indicating a balance between buyers and sellers, with no overbought or oversold signals. The stock is also midway between the lower Bollinger band at 75.21 euros and the upper band at 78.33 euros, showing a contained volatility of 3.23% over a month. The support threshold at 75.12 euros remains a floor to watch in case of extended declines, while the immediate resistance at 79.60 euros is the target in case of a rebound, in a context where a negative Chaikin Money Flow (CMF) of -0.17 suggests capital outflows in recent sessions.
Danone Posts Strong Q3, Reaffirms Annual Goals
The group reported a strong third quarter at the end of October, with revenues of 6,876 million euros, up 4.8% on a comparable basis, driven by a 13.8% growth in China, North Asia, and Oceania. Danone has reaffirmed its annual targets, aiming for a revenue growth of between 3% and 5% by 2025 on a comparable basis, with current operating income growing faster. The company's strategy relies on targeted acquisitions, including Kate Farms in medical nutrition in the USA and The Akkermansia Company in Belgium. These initiatives are part of the Renew Danone plan, focused on health and innovation, as the group navigates an environment marked by unfavorable exchange effects and tensions in some markets such as waters in Mexico. The next annual results are expected on February 20, 2026, providing visibility on the group's ability to meet its commitments.
